Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B... ( DES PLAINES Ill. Sept. 1 /- Abbott (N...)

Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment

Date:9/1/2010

DES PLAINES, Ill., Sept. 1 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results.

The Abbott RealTime HBV assay, based on real-time PCR (polymerase chain reaction) technology, is now available for laboratories that use the Abbott m2000 automated instrument system for molecular diagnostic testing. The test offers sensitive measurement (quantitation) of HBV in human plasma or serum from individuals chronically infected with HBV.

The assay is intended for use as an aid in the management of patients with chronic HBV infection undergoing anti-viral therapy. The assay can be used to measure HBV DNA levels at baseline and during treatment to aid in assessing response to treatment. Assay results must be interpreted within the context of all relevant clinical and lab findings. Use of the assay to determine the clinical stage of HBV infection has not been established. Clinical performance characteristics have been established for individuals treated with adefovir dipivoxil. The assay is not intended as a screening test for HBV or as a diagnostic test for confirming the presence of HBV infection.

"The Abbott RealTime HBV assay, which is the first and only automated HBV viral load test approved by the FDA, is an important tool for helping physicians make and adjust treatment decisions for newly diagnosed patients and those taking anti-viral medications," said Stafford O'Kelly, head of Abbott's molecular diagnostics business. "The test will also help improve laboratory productivity by
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent

Post Your Comments:

(Date:5/17/2013)... 17, 2013 Technology advances have had a ... with a constantly evolving communication environment, companies need ... communicating with internal executives. It is challenging, however, ... tactics and tools that are part of today,s ... study, Best Practices, LLC explores the various internal ...

(Date:5/17/2013)... -- United Medical Education, a company that provides online ... Life Support (PALS) and Basic Life Support (BLS), is ... course manuals. In order to gain access to ... account with the company. By offering the free learning ... is setting a precedent among similar companies. ...

(Date:5/17/2013)... 17, 2013 /PRNewswire-iReach/ -- The escalation of new ... placing renewed emphasis on alternate delivery technologies. Alternate ... number of factors are converging to create both ... their delivery device partners . These include new ... growing trend toward self-administration for chronic diseases, shifting ...

Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2 ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2 Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2 Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3

[0] Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness [0] ACLS Online Course Manuals are Now Available at No Cost through United Medical Education [0] Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment

... and LOS ANGELES, Oct. 14 /PRNewswire-Asia/ -- China,Yongxin Pharmaceuticals, ... Company"), a leading manufacturer, distributor and,retailer of pharmaceuticals in ... second quarter of 2009 which ended June 30,2009. , ... of 2009 were essentially flat at,approximately $14.6 million compared ...

... VSCP ), a leading provider of quantitative imaging for ... chief business and financial officer, will be presenting a corporate ... Forum in San Francisco, California. Ms. Henderson is scheduled to ... 2009 at the Palace Hotel, San Francisco. , A live ...

China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results VirtualScopics to Present at the 8th Annual Bio Investor Forum

(Date:5/19/2013)... (PRWEB) May 20, 2013 Due to ... with online advertising, MileageAds.com has decided to invite bloggers ... through their ad network. , Businesses in the ... success with online marketing, specifically with ad networks. ... information and legal services and are unsure where to ...

(Date:5/19/2013)... physicians are key decisionmakers for nearly half of all ... in reducing health care costs, according to a new ... admissions from the ER increased by 17 percent over ... hospital admissions between 2003 and 2009. Hospital inpatient ... accounting for 31 percent of the nation,s health care ...

(Date:5/19/2013)... New York, NY (PRWEB) May 19, 2013 ... tickets for his two concerts in Vegas in October ... 20th. Additionaly, during the spring and summer months of ... the country. , Whenever people hear “It’s Five ... and hear the voice of Jimmy Buffett inside their heads. ...

(Date:5/19/2013)... (PRWEB) May 19, 2013 Daily Gossip reporters ... 17 Cheat Foods That Burn Fat to a ... readers. , The review is a detailed ... by the writer's recommendation. , The two nutritionists have discovered ... is responsible for the caloric intake and expenditure of our ...

(Date:5/19/2013)... May is officially known as Skin Cancer Awareness ... Australia, the country's forerunner in fashionable children’s sun ... to kick off their month long mission to bring ... staggering number of cancer cases diagnosed each year, the ... out what’s causing the epidemic and how to stop ...

Breaking Medicine News(10 mins):Health News:Mileageads Ad Network Now Invites Bloggers and Business Owners in Mesothelioma Sector to Advertise on Their Ad Network 2 Health News:ER docs are key to reducing health care costs 2 Health News:ER docs are key to reducing health care costs 3 Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 2 Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 3 Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2 Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 2 Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 3

[0] Mileageads Ad Network Now Invites Bloggers and Business Owners in Mesothelioma Sector to Advertise on Their Ad Network [0] ER docs are key to reducing health care costs [0] Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time [0] The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip [0] Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents

... Multimedia Effort to Launch Contact Lenses in Puerto ... ... 28 Johnson & Johnson Vision,Care, today announced a multi-faceted marketing campaign ... Contact Lenses in Puerto Rico, the Caribbean and Central,America., Following its ...

... in Heavy Rotation Through Primary, OAKLAND, Calif., ... crucial,primary vote Tuesday, the National Nurses Organizing Committee/California,Nurses ... Ohio with,an emphatic message to the presidential candidates ... healthcare reform., The 60-second radio ad is ...

... lupus erythematosus (SLE), commonly known as lupus, can affect ... skin, kidneys, heart, nervous system, and brain. Along ... and skin rashes, neurologic and psychiatric events often accompany ... 37 and 95 percent of SLE patients experience signs ...

... Kimmel Cancer Center in Philadelphia have shown that they ... laboratory and in experimental animal models by blocking a ... The work proves that the protein, Stat5, is both ... is a viable target for drug therapy. , The ...

... Year 2007 Highlights, - Revenue for the fourth quarter was $469.5 ... year was $1.8 billion, a 40% ... - Average occupancy for the fourth quarter was 90.6% and for the full ... from 90.4% for the full year of 2006., - Same store Facility ...

... 27 Actavis Group, the,international generic pharmaceuticals company, ... U.S. Food & Drug Administration., The four ... generic equivalent of,Bontril(R) tablets by Valeant Pharmaceuticals, are ... sales of Phendimetrazine tartrate tablets,had annual sales of ...

Eyes on Puerto Rico: Johnson & Johnson Markets New Contact Lenses Directly to Consumers Nurses Launch Major Ohio Radio Ad Campaign Telling Candidates: Stop Selling Insurance and Back Real Reform Autoantibodies and neuropsychiatric events in lupus Blocking protein kills prostate cancer cells, inhibits tumor growth, Jefferson scientists find Brookdale Announces Fourth Quarter and Full Year 2007 Results Actavis Extends Portfolio With Four New Products in the U.S.

When You Need Optimal Patient Comfort with Minimal Weight at a Nonunion Site...Demand The OrthoPak Noninvasive Bone Growth Stimulator. , ,Most Appropriate for the Proximal Femur, Metatarsal/Tar...

... Pulsed ElectroMagnetic Field (PEMF) bone growth stimulation ... option for long bone and small bone ... cast, orthopedic brace, or clothing without lessening ... in one compact, lightweight unit including success ...

Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....

... Cannulated Interference Screws. Optimal ... and graft selection options. ... without deformation, and chamfered ... threaded atraumatic tissue fixation. ...

Medicine Products:

BioElectron Orthopak Physio-Stim Bone Growth Stimulator Interference Screws ABSOLUTE Absorbable Cannulated Interference Screws